ImClone Investigational Site

Brno 656 53

0 studies enrolling now · 3 studies all time

What they study most

Adenocarcinoma, Breast Cancer, Colorectal Cancer, Gastric Cancer

Studies at this site

• Phase III Study of Docetaxel + Ramucirumab or Placebo in Breast Cancer — Completed
• Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Participants With Gastric Cancer and Adenocarcinoma — Completed
• Study of Irinotecan and Cetuximab Versus Irinotecan as Second-Line Treatment in Patients With Metastatic, EGFR-Positive Colorectal Cancer — Completed